New diabetes clinical trial: Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics
Published on: September 28, 2021 at 09:30PM
Condition: Cystinuria
Intervention: Drug: Dapagliflozin
Sponsor: University of California, San Francisco
Not yet recruiting
https://ift.tt/3oec977
Condition: Cystinuria
Intervention: Drug: Dapagliflozin
Sponsor: University of California, San Francisco
Not yet recruiting
https://ift.tt/3oec977
Comments
Post a Comment